semaglutide cause bone loss JEFF ROSE, CFP® | The Ozempic conversation just got more complicated. A new study of 146,000 adults links GLP-1 drugs to a higher risk of osteoporosis New studies have raised fresh

Retatrutide is an investigational once-weekly triple agonist targeting the GIP, GLP-1, and glucagon receptors pathways involved in appetite, satiety, glucose metabolism, and energy balance

What you need to do: Glutathione: take a precautionary dose of liposomal Glutathione, as this boosts endogenous Glutathione levels and will help protect the liver

This is the question almost nobody asks and almost no online telehealth platform can answer

Semaglutide (18 studies), tirzepatide (9 studies), and liraglutide (24 studies) were separately examined

Discontinuation rates due to adverse events were 12.218.2% across retatrutide groups versus 4% placebo